MedTrace Logo

Resveratrol and Exercise to Treat Functional Limitations in Late Life

NCT02523274 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-13

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to evaluate the effects of combining physical exercise with a resveratrol supplementation on the physical function of older adults.

Conditions

  • Aging

Interventions

DRUG

Resveratrol

Dietary compound commonly found in grapes and red wine. Will be given in 250 mg/day and 1000 mg/day dosages

DRUG

Placebo

Vegetable-based cellulose

BEHAVIORAL

Exercise

Multi-modal exercise regimen, 3 days/week

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Alabama at Birmingham

    collaborator OTHER

  • University of Florida

    lead OTHER

Principal Investigators

  • Thomas Buford, PhD · University of Alabama at Birmingham

  • Stephen Anton · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-05-31
Completion
2019-07-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523274 on ClinicalTrials.gov